Malaria infected red blood cells release small regulatory RNAs through extracellular vesicles by Babatunde, Kehinde Adebayo et al.
1Scientific REPORTS |  (2018) 8:884  | DOI:10.1038/s41598-018-19149-9
www.nature.com/scientificreports
Malaria infected red blood cells 
release small regulatory RNAs 
through extracellular vesicles
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The parasite Plasmodium falciparum causes the most severe form of malaria. Cell communication 
between parasites is an important mechanism to control population density and differentiation. 
The infected red blood cells (iRBCs) release small extracellular vesicles (EVs) that transfer cargoes 
between cells. The EVs synchronize the differentiation of the asexual parasites into gametocytes to 
initiate the transmission to the mosquito. Beside their role in parasite communication, EVs regulate 
vascular function. So far, the exact cargoes responsible for cellular communication remain unknown. 
We isolated EVs from cultured iRBCs to determine their small RNA content. We identified several types 
of human and plasmodial regulatory RNAs. While the miRNAs and tRNA-derived fragments were the 
most abundant human RNAs, we also found Y-RNAs, vault RNAs, snoRNAs and piRNAs. Interestingly, 
we found about 120 plasmodial RNAs, including mRNAs coding for exported proteins and proteins 
involved in drug resistance, as well as non-coding RNAs, such as rRNAs, small nuclear (snRNAs) and 
tRNAs. These data show, that iRBC-EVs carry small regulatory RNAs. A role in cellular communication is 
possible since the RNAs were transferred to endothelial cells. Furthermore, the presence of Plasmodium 
RNAs, in EVs suggests that they may be used as biomarker to track and detect disease.
Malaria affects over 400 million individuals worldwide every year, killing about 0.5 million1. The complications of 
the disease arise during the blood stage, which is characterized by symptoms such as cerebral malaria, severe ane-
mia, metabolic acidosis and respiratory distress2. During the blood stage, the parasites release toxic factors that 
contribute to inflammation. In addition, iRBCs secrete small vesicles that contain human and parasite-derived 
biomolecules3. The EVs derived from iRBCs are elevated in patients suffering from malaria and are particularly 
elevated in severe disease4. Interestingly, the severity of the disease significantly correlates with the level of EVs in 
the plasma5. Therefore, EVs might be used as biomarker to track the progress of the disease and treatment. EVs of 
a size between 100–300 nm have been characterized to contain both human and parasite proteins3,6.
Surprisingly, EVs induce the conversion of parasites into gametocytes3. Thus, EVs act like a master regulator that 
orchestrate and synchronize the conversion to gametocytes to optimize the transmission of the parasites to mosquito. 
Although the molecules responsible for the commitment have not yet been identified, EVs transfer nucleic acids from 
parasite to parasite as demonstrated by the transfer of a plasmid DNA encoding for a gene conferring resistance to a 
particular drug6. Only the parasites that have acquired the selection marker can grow under the drug selection pressure. 
While these experiments demonstrated the potential of EVs to carry and transfer functional nucleic acids between 
parasites, the authors characterized for the first time a mechanism of communication between parasites. Interestingly 
malaria EVs contain RNAs, in particular small RNAs7. However so far, little is known about the nature of these RNAs.
During malaria, host derived miRNAs constitute essential mediators of cellular communication. In fact, func-
tional miR451a, a miRNA expressed in RBCs is transferred from iRBCs to endothelial cells via EVs. Remarkably, 
miR451a is bound to Argonaute-2 and forms a functional silencing complex. Once transferred, miR451a destabi-
lizes specific mRNA to regulate endothelial cell barrier function7.
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Besides miRNAs, many other small RNA species have regulatory functions. However so far most of the analy-
sis of EV RNAs have focused on miRNAs. High-throughput RNA-Seq has allowed the identification of new small 
RNAs with regulatory properties. Such as tRNA-derived fragments, piwi-RNAs (piRNAs), Vault RNAs (vtR-
NAs), Y RNAs and snoRNAs8,9. Furthermore, P. falciparum might use EVs to shuttle its own plasmodial RNAs. 
Currently no study has directly addressed the RNA composition of EVs.
Here we collected EVs derived from in vitro cultures of P. falciparum and performed RNA-Seq to characterize 
for the first time the small RNA content of iRBCs derived EVs. We found several species of host as well as plas-
modial RNAs. Remarkably, EVs transferred Plasmodium RNAs to endothelial cells. While our data highlight a 
rich repository for infection-related biomarkers, we also identify an entirely new strategy by which Plasmodium 
likely manipulates host defensive barriers. Further exploration of EV functions may identify novel strategies for 
malaria control.
Results
Characterization and properties of extracellular vesicles isolated by differential centrifuga-
tion. To further investigate the potential regulatory RNAs present in EVs, we collected EVs from P. falciparum 
iRBCs cultures and purified the vesicles by ultracentrifugation. To verify the vesicular structure of the isolated 
EVs, we used transmission electron microscopy (TEM). Analysis by TEM revealed that EVs have a size of 100–
250 nm and demonstrated an intact lipid bilayer (Fig. 1a). The morphology is consistent with EVs as previously 
reported measuring about 150 nm in size as observed by TEM and the nanoparticle tracking system (Fig. 1b). 
Larger EVs observed by the nanoparticle tracking system might be the result of aggregate formation3. The purity 
of the EV preparations was determined by western blotting with a panel of antibodies. EVs were enriched in 
the lipid raft protein stomatin as well as the parasite protein RESA, while Bip a plasmodium protein specifically 
expressed in endoplasmic reticulum was absent (Fig. 1c).
To further define the EV cargoes, we isolated total RNA from EVs and intact iRBC cells. The quantity and 
quality of isolated RNA were determined using an Agilent Bioanalyzer. In contrast to intact cells, total RNA bio-
analyzer profiles indicated that iRBC EVs contain minor amounts of 18 S and 28 S rRNA species. Furthermore, 
the RNA composition is different in EVs in comparison with intact cells, with enrichment in small RNAs below 
300 nt in length in the vesicles (Fig. 1d).
Figure 1. Extracellular vesicles isolated from P. falciparum carry RNA. (a) Transmission electron microscopy 
of EV preparation, purified EVs show individual EVs and a few clumps of varying sizes and intact lipid bilayers. 
The scale bar is 100 nm. (b) Representative particle size distribution from purified EVs. The concentration and 
size are determined by Nanoparticle Tracking Analysis. One representative experiment is shown. (c) Isolated 
EVs were confirmed by Western Blot for the enrichment of EV markers stomatin and RESA and negative for 
the endoplasmic reticulum Bip. (d) Total and Small bioanalyzer profiles of EV RNAs and total cell RNA show 
enrichment of small RNAs in EVs. One representative experiment is shown.
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Extracellular vesicles derived from iRBCs contain small RNAs. Next to decipher the RNA content of 
EVs, we generated small RNA libraries of the samples for small RNA-Seq from three biological replicates of EVs 
derived from iRBCs. The same 3D7 parasite strain was cultured in RBCs of three different donors.
Small RNA sequencing of the EV libraries yielded a total of 83’319’134 raw reads that were pre-processed 
and trimmed to remove adapter sequences using sRNAbench to identify high quality reads that were considered 
for further analysis. After processing for adapter and unmapped sequences, the number of reads was reduced to 
26’647’563, 8’126’655 and 11’925’918 respectively. The total number of reads mapping to the human genome was 
43’689’670, whereas the total number of reads mapping to the P. falciparum genome was 3’010’466. Therefore, the 
proportion of P. falciparum reads was 6.4% versus 93.6% of human (Fig. 2a and Table 1).
Since small RNAs have regulatory functions, we focused our analysis on the identification of small RNAs. As 
expected miRNAs and tRNAs were widely and abundantly expressed. Then we performed a detailed quantifica-
tion of annotated RNAs to functionally categorize the human small RNAs. The average across all three samples 
was calculated to obtain a representative profile of biological diversity between donors. Of total reads, the miR-
NAs were the most abundant small RNA species with 42.3%, followed by 34.79% of tRNAs, 8% piRNA, 7% Y 
RNA, 3.60% Metazoa Signal Recognition Particle (SRP) RNA, 2.17% U-RNA, 1.17% Vault RNA, 0.48% snoRNA 
and 0.14% pre-mature RNA (Fig. 2b). The reads map to all the human chromosomes in particular chromosome 1 
and 3 (Fig. 2c). Since the chromosomes do not have the same size, we then normalized by size to look for specific 
enrichment. Since there are several copies of mitochondrial DNAs per cell, we excluded them from the analysis. 
After normalization, there was an enrichment in chromosome 18 and 22 (Fig. 2d).
EVs contain a subset of human regulatory miRNAs. A total of 305 human miRNAs were identified in at 
least one sample. While we identified many miRNAs, only a few sets were highly expressed7 (Fig. 3a). A total of 61 
miRNAs were present in all the 3 samples and among them, miR451a was the most abundant (515 RPM) accounting 
for 26.9% of the total miRNA reads, followed by miR486-5p (22.51%), miR92a-3p (9.37%) and miR103a-3p (6.34%). 
The most abundant miRNAs represent over 65% of the total reads (Fig. 3a). Because only a few miRNA species 
accounted for the majority of miRNA sequencing reads, we focused on the top 16 miRNAs for our analysis of poten-
tial regulatory targets. We performed Kyoto Encyclopedia of Genes and Genomes (KEGG)10 pathway enrichment 
analysis of genes targeted by miRNAs relative to all target genes in miRDB (http://www.genome.jp/kegg). We found 
that pathways involved in cell cycle, cell adhesion and associated to cancer were significantly enriched (Fig. 3b). In 
addition to mature RNAs, we found pre-mature miRNAs. However, the RPM for the pre-mature miRNAs were low 
and only 3 had an RPM above 1. In fact, pre-mature miR451a and miR137 were the highest expressed with 3.4 and 
1.5 RPM respectively. Although the abundance was low, they were expressed in all three preparations (Fig. 3c).
The human tRNAs represented an abundant small RNA category in our samples. We found that 60 tRNAs 
were expressed out of which 42 tRNAs were expressed in all the three biological replicates. However over 75% of 
the reads were derived from tRNA-GlyCCC, tRNA-LysTTT, tRNA-PheGAA and tRNA-LysCTT. With an average 
of 615 RPM, tRNA-GlyCCC represents about 44% and tRNA-LysTTT 16% of the total tRNA reads (Fig. 3d). All 
the tRNAs identified were tRNA fragments, we did not discover full length tRNAs. We found the 3′ and 5′ halves 
of tRNA –GlyCCC, with each half consisting of about 32 nt. The 5′half was slightly more abundant than the 3′. In 
addition, we found 5′tRNA-LysTTT of about 24 nt. Finally, tRNA-PheGAA, was composed of a 5′tRNA fragment 
and a 3′ fragment of about 24 nt each (Fig. 3e and Supplementary Figure 1).
Extracellular vesicles contain a subset of Y-RNA, Vault RNA, SRP-RNA, U RNA, piRNA and 
snoRNAs. Although miRNAs and tRNAs have essential biological functions, other small non-coding RNAs 
have in general not been characterized in EVs. Our sequencing strategy favors the identification and quantifica-
tion of additional RNAs. Apart from the miRNAs and tRNA fragments, other RNA biotypes were abundantly 
present in iRBC-EVs, including Y-RNA, vault-RNA, SRP-RNA (7SL-RNA), U-RNA, Piwi-RNA and sno-RNA.
Y-RNAs, which range in size from 83 to 112 nt, are cytoplasmic non-coding RNAs that are conserved in 
the animal kingdom11–13. Most Y-RNAs are bound to the proteins Ro60 and La to form Ro ribonucleoproteins 
(RNPs), which might be targeted by the immune system in autoimmune disease14. There are four non-coding 
Y-RNAs in humans (hY1, hY3, hY4 and hY5 RNAs). We identified 2 Y-RNAs in our samples, RNY4 (319.37 RPM) 
and RNY1 (3.2 RPM), (Fig. 4a). Therefore, RNY4, which was identified in all 3 replicates accounted for 99% of the 
RPM for the total Y-RNAs15.
Vault RNAs are the RNA components of Vault ribonucleoprotein particles, which are located in the cytoplasm. 
The three human vRNA genes contain 88 (vRNA2 and vRNA3) or 98 nucleotides (vRNA1) single-exon polymer-
ase III transcripts16. A fourth vRNA-related sequence, vRNA4, presumed to be silent pseudogene is located on 
chromosome X16. Only 1 Vault RNA was identified, VTRNA1-1 (51.31 RPM) having the highest level of expres-
sion and representing 99.5% of the vRNA reads (Fig. 4b).
Next, we identified 8 different SRP-RNAs, with 4 of them expressed in all three samples. RN7SL5P was the most 
abundant with an average RPM count of 107, which represents 68% (Fig. 4c) of all the SRP-RNAs. SnRNAs, also 
commonly referred to as U-RNA are highly conserved non-coding RNAs located in the nucleus and associated with 
Sm ribonucleoproteins as well as other specific proteins, to form small nuclear ribonucleoproteins. They participate 
in the splicing of precursors mRNAs. SnRNAs have an average size of 150 nt. We identified a total of 6 different U 
RNA (U1, U2, U3, U4, U5 and U6) with U1 being the most abundant, representing 70% of the total counts (Fig. 4d).
Piwi-associated RNAs, as compared with miRNAs, are a distinct class of 24–31 nucleotide-long RNAs pro-
duced by a Dicer-independent mechanism from single-stranded precursor transcripts expressed from intergenic 
regions termed piRNA clusters17. In total, we detected 44 piRNAs of which 21 were expressed in all three samples. 
The three most abundant piRNAs (PIR13807, PIR58593 and PIR57690) together represent approximately 33% of 
the total piRNA reads (Fig. 4e).
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Figure 2. Characterization of small RNAs by NGS. (a) Composition of reads mapping to human and P. 
falciparum genomes. (b) Distribution of iRBC EV small RNAs. Segments of the bar indicate the percent of reads 
attributed to each RNA biotype among all RNA reads that mapped perfectly to known sequences, averaged 
across 3 biological replicates is shown. (c) Reads aligning to coding genes were mapped back to the human 
chromosomes and represented as the % reads aligning to each chromosome. (d) Reads aligning to coding 
genes were mapped back to the human chromosomes and after normalization to the nucleotide size of the 
chromosome.
Sample 1 Sample 2 Sample 3 Average
Sequencing reads 68003555 33846106 35423492 45757717
QC passed reads 51798945 14610329 16909860 27773044
Mapped to human genome 24968040 7274347 11447283 14563223
Mapped to plasmodium falciparum genome 1679523 852308 478635 1003488
Identified miRNAs 219 87 276
Table 1.  Sequencing statistics.
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Small nucleolar RNAs (snoRNAs) are a class of small RNA molecules that primarily guide chemical modifica-
tions of other RNAs, mainly ribosomal RNAs and small nuclear RNAs18. We identified 7 snoRNAs with a total of 
35 RPM (Fig. 4f). SNORD116-2 was the most abundant with 16 RPM and 46% of the total count.
P. falciparum iRBCs release plasmodial RNAs. Next, to investigate whether plasmodial RNA is released 
in the supernatant, we labelled newly transcribed RNAs in tightly synchronized iRBCs. Ring stage parasites were 
incubated with 5-ethynyl uridine (EU), which is incorporated into RNA during transcription. First, we monitored 
the cells for active transcription and, only iRBCs were positive for EU as measured by flow cytometry (Fig. 5a). 
Figure 3. Profiling of human miRNAs and tRNAs isolated from P. falciparum infected EVs. (a) Top 16 most 
highly expressed unique miRNAs in EVs. Left axis and bars: percent of total miRNA reads that mapped to each 
of the top 16 most abundant miRNAs. Error bars are standard deviation (n = 3). Right axis and line: cumulative 
percent of total miRNA reads. (b) Significantly (Benjamini Hochberg corrected P value < 0.05) enriched KEGG 
pathways for target genes. The number of miRNA involved in targeting at least one gene in a given pathway 
are shown in parentheses. (c) Distribution of human pre-mature miRNAs (n = 3). (d) Distribution of known 
tRNA sequences based on the total read counts. tRNA sequences are categorized by number of read counts 
corresponding to each individual tRNA (n = 3). (e) Based on the small RNA-seq results, only tRNA fragments 
were identified in EVs. Shown are examples of tRNA structures for each species depicting the boundaries of the 
identified tRNA fragment. The read density at each position is shown as a heatmap.
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Then, we collected the supernatants and freshly transcribed RNA was detected by flow cytometry in the superna-
tant with more than 80% of events being positive for freshly synthesized RNAs. Since RBCs are transcriptionally 
inactive, we assume that the labelled RNA is derived from the parasites (Fig. 5a). This experiment gave us strong 
confidence that EVs contain plasmodial RNA. In order to identify the plasmodial sequences, we aligned our 
RNA-Seq results generated previously to the P. falciparum genome (Plasmodium 6.1). We found that several plas-
modial RNAs including tRNAs, rRNAs and mRNAs were present in EVs. In total, we identified 126 RNAs map-
ping to the Plasmodium genome of which 28 were identified in all the 3 samples (Supplementary Table 1). Most of 
the reads mapped to chromosome 1 (10.7%), chromosome 5 (33.1%), chromosome 7 (33.6%) and chromosome 
13 (9.42%), only a minor amount mapped to mitochondrial and apicoplast DNAs (0.75 and 0.30%, respectively) 
(Fig. 5b). Then, we normalized by the length of the DNA, excluding mitochondrial and apicoplast DNAs since 
they are present in several copies per cell. Chromosome 1, 5 and 7 keep the highest number of mapped RNAs 
(Fig. 5c). Most of the RNA transcripts are derived from structural RNAs. There are a few putative novel ncR-
NAs, however their abundance is low. We have found mostly rRNA, tRNA and snoRNA in the three replicates 
from Plasmodium (Fig. 5d). In addition, a large amount of transcripts coding for proteins exported to the RBC 
Figure 4. Functional characterization of small RNAs. (a) Distribution of Y-RNA (b) Vault-RNA. (c) 
Distribution of Metazoa-RNA. (d) Distribution of U-RNA. (e) Distribution of PIWI-RNAs. (f) Distribution of 
snoRNAs.
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cytosol such as RESA, ETRAMP and mRNAs from the PHIST family including Mal7P1.172 and PF0_0137 were 
present. Furthermore, EVs contain a large amount of apicoplast tRNAs19 and mitochondrial rRNAs (Fig. 5e), 
including tRNA-GLu-1, tRNA-Ser1, tRNA-Met1, tRNA-Pro1, tRNA-Arg1, tRNA-Trp1, tRNA-Arg3, tRNA-Cys1, 
Figure 5. EVs contain plasmodial RNAs. (a) Quantification of P. falciparum RNAs transferred to EVs. Infected 
RBCs were labeled with Click-It RNA Alexa Fluor 488. After 30 h. of incubation, EVs were collected and EU 
incorporation was analyzed by Flow Cytometry. (b) Distribution of the reads mapped to the P. falciparum 
genome according to the corresponding chromosomes. (c) Distribution of the reads mapped to the P. 
falciparum according to the size of the chromosome. (d) Types of Plasmodium genes in the EVs by RNA-Seq. (e) 
Extracellular vesicles contain a large number of Apicoplast tRNA and Mitochondrial rRNA. (f) RNA expression 
is different in EVs than mixed stage parasite expression pattern. (g) EV RNA composition is different that of 
iRBC. The expression levels shown by RNAseq of EV has no detectable correlation with that of steady state 
iRBC, showing that EV is not merely a smaller form of iRBC. Neither parametric (Pearson’s R) nor parametric 
correlations (Kendell’s tau) analysis detected correlation between EV and iRBC at any time points with 
correlation larger than 0.001. The X-axis shows the average steady state RNA expression levels.
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pre-tRNA-Pr01, tRNA-SelCys1. Interestingly several RNAs were involved in drug resistance, such as PFE1150w 
(multidrug resistance protein 1), PFL1410c (ABC transporter, multidrug resistance-associated protein 2), 
PF13_0238 (Kelch-13).
We then compared the RNA EV expression profile with stage specific RNA profile of the blood stage and 
found that EV RNAs are mostly derived from genes with peak expression in merozoites and early rings. Very few 
RNAs are derived from other stages (Fig. 5f). Importantly, there was no direct correlation of the gene expression 
levels between iRBC and EV transcriptome (Fig. 5g).
Plasmodial extracellular RNAs are associated with EVs. The extracellular RNAs found in the plasma 
can be associated with proteo-lipid complexes and the complexes containing RNAs might be co-purified with EVs 
during ultracentrifugation. To exclude the possibility that plasmodial RNA molecules originate from protein–
lipid complexes present in our EV preparation or in the conditioned medium derived from in vitro P. falciparum 
iRBCs, we treated EVs with proteinase K20. In fact, proteolytic digestion of the protein complex stabilizing the 
plasmodial RNAs would release the RNAs and render them sensitive to degradation. However, RNAs protected 
inside a vesicular structure would not be expected to show sensitivity to proteolysis. We treated EVs with or with-
out proteinase K at 55 °C. The samples were incubated for 0, 15, 30 and 45 min followed by RNA extraction and 
quantification by qPCR. In fact, MAL5_18S, 28 S rRNA and PFA0110w were protected from degradation inside 
EVs (Fig. 6a–c).
To further confirm that the plasmodial RNAs are associated with EVs, we performed size exclusion chroma-
tography, which allows efficient separation of vesicles from protein lipid complexes that are smaller and elute later 
than vesicles. For this purpose, we cultured iRBCs and collected the conditioned supernatant after 48 hours. We 
isolated 14 fractions by chromatography and most of the proteins were eluted in the latest fractions (9–12), only 
a minor portion was eluted in the fraction 5 that corresponds to the EV fractions (Fig. 6d). We can assume based 
on our standards that most of the proteins in the supernatant are albumin, gamma-globuline. We then isolated 
total RNA including small RNAs from each isolated fraction and performed qPCR. As miR451a, all the tested 
plasmodial RNAs were detected in fraction 5, which corresponds to the EV fraction (Fig. 6e–i). Altogether these 
experiments demonstrated that Plasmodium RNAs are located in EVs.
Plasmodium EVs deliver RNA cargo to human endothelial cells. To further understand the sig-
nificance and potential function of the plasmodial RNAs in cellular communication, we tested their stability 
and potential transferability to endothelial cells. For this purpose, we incubated human bone marrow derived 
endothelial cells with (BMEC) EVs and noticed that the EVs were quickly taken up by the cells (Fig. 7a). We then 
monitored the transfer of RNAs by qPCR. No plasmodial RNA was detected in the absence of EVs. However, 
after a 12-hour EV-incubation the level of RNAs increased in endothelial cells. Therefore, the vesicles can act as 
a shuttle to transfer plasmodial RNAs to human endothelial cells. The inhibitor of the RNA Polymerase II and 
III (α-amanitin) was not able to inhibit the transfer, demonstrating that there was no active transcription of the 
Plasmodium genes in endothelial cells (Fig. 7b). To gain insight into the potential role of EV RNAs, we performed 
GO analysis. GO function analysis revealed that the RNA EVs were involved in RNA binding (Fig. 7c). Whereas 
GO cellular localization demonstrated that most of the RNAs are associated with the cytosol or vesicle mem-
branes (Fig. 7d). Finally, the GO biological process showed that the RNAs are involved in translation regulation, 
regulation of gene expression and regulation of catalytic activity (Fig. 7e). Taken together these data further indi-
cate a potential role of extracellular RNAs in regulation and cellular communication. Finally, we hypothesized 
that sequences that are identical between P. falciparum and human might have cross-regulatory function. From 
our RNA-Seq data, we identified several sequences that aligned to human and plasmodial genomes (Table 2).
Discussion
To date, a detailed analysis of the nucleic acid composition of malarial EVs has been lacking and only the host 
miRNA composition has been determined7. This study is the first systematic description of EV small-RNAs in 
P. falciparum iRBCs. With our approach, we found that EVs contain human, as well as plasmodial RNAs with 
potential regulatory functions. Interestingly the EVs were able to deliver plasmodial RNAs to endothelial cells 
suggesting a potential role in pathogen-host cellular communication. Furthermore, the full characterization of 
the EV RNA content offers a large number of promising new biomarkers for the diagnosis and the prediction of 
the progression of the disease.
Transfer of functional RNAs between cells via EVs is a universal mechanism of cellular communication21. 
Here, we identified several small RNAs with regulatory function. The host miRNAs were the most abundant 
RNA species detected in the EV samples. miRNAs are crucial in regulating posttranscriptional gene expression22. 
Recently miRNAs were shown to shuttle from cell to cell via EVs to mediate cellular communication23. In the con-
text of malaria, we have previously shown that miR451a regulates cellular functions after transfer to endothelial 
cells7. Here, in addition to miR451a, we identified miR486-5p and miR92a-3p as the highest expressed human 
miRNAs. All the three miRNAs are expressed in RBCs and play an essential role in their maturation24,25. They 
regulate erythropoiesis by inhibiting proliferation or differentiation, protecting erythroid cells from oxidative 
stress or controlling iron transport and metabolism. However, these miRNAs have a function beside their role 
in RBC maturation26,27. There is only little overlap between the genes targeted by the EV miRNAs. However, 
the miRNAs target the same functional pathways. This raises the possibility that the transferred EV miRNAs 
(including mir451a, mir486-5p and mir92a-3p) might act synergistically to target multiple genes part of the same 
pathways involved in malaria infections and pathogenesis. In fact, our analysis of the KEGG pathways showed 
that iRBC-EV miRNAs targeted pathways involved in cell proliferation and adherence junction. Although lit-
tle is known about the specific role of iRBC EVs in Cerebral Malaria pathogenesis, the concentration of EVs 
derived from RBCs, platelets, endothelial cells and leucocytes are markedly elevated in patients and there is a clear 
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association between EV concentration and pathogenesis. More direct evidences for a role of EVs are coming from 
the rodent model of malaria. The reduction of EVs in transgenic mice or with drugs confers protection against 
severe disease and cerebral malaria. Furthermore, EVs isolated from mice with malaria are potently activating 
macrophages4,5,28–33. It remains to be demonstrated whether EV RNAs derived from different cellular sources 
can act synergistically to modulate the pathogenesis. In addition to miRNAs, we identified numerous host tRNA 
fragments. This is in agreement with other studies that found tRNAs in immune cells derived EVs8, in semen 
EVs9 and in EVs secreted by pathogens such as Trypanosoma cruzi34 and leishmania35. While tRNAs, which are 
73–90 nt in length are components of the translational machinery, a functional role in gene regulation has been 
proposed for tRNA fragments. In our samples the most abundant tRNA (tRNA-Glyc) was derived from a 5′ and 
Figure 6. Plasmodial RNAs are contained inside the EVs. (a) The RNAs are protected from proteinase K 
digestion, EVs were treated with proteinase K (5 mg/ml, close symbols) or untreated (open symbol) at 55 °C. At 
times indicated aliquots were removed and the RNA was isolated and the expression of (a) MAL5_18S, (b) 28 S 
rRNAs, (c) PFA0110w, was analyzed by qPCR. The mean + /− s.d. of one representative experiments of three 
is shown. (d) Elution profile of conditioned media collected from iRBC culture as measured by absorbance at 
280 nm. Points represent the mean +/− s.d. of three experiments performed in triplicate. (e) Fractions from 
conditioned media were assayed for (e) PFA0110w, (f) MAL5_18S, (g) 28 S rRNA, (h) PF11_0381a and (i) 
miR451 using absolute quantification by qPCR. The mean + /− s.d. of one representative experiment is shown 
(n = 3).
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3′ halves. In addition, we found 5′ end tRNA fragments, predominantly 30–34 nt tRNA halves derived from 
tRNA-Lys and tRNA-Phe. These derivatives of tRNAs are not degradation products but are specific cleavage prod-
ucts that function in pathophysiological conditions36. During oxidative stress, angiogenin cleaves the full-length 
mature tRNAs and produces 5′ and 3′ halves that are 30–40 nt in length37. The 5′ ends of these tRNA halves inhibit 
translation by displacing components of the translation initiation complex38. tRNA fragments are heterogeneous 
in size, nucleotide composition, biogenesis and function. Besides tRNA halves, shorter tRNA-derived fragments 
(tRFs) in the size range of 13–30 nt have been described in organisms spanning all domains of life. These RNAs 
can be both constitutively generated and produced in the context of stress. Although angiogenin is not detected in 
EVs3, it is expressed in RBCs39. The oxidative environment that triggers the parasite in the RBCs might favor the 
generation of tRFs that are then secreted via EVs. While, the role of tRNA in cellular communication is unknown, 
their biological function range from translation control, over RNA silencing, to regulating apoptosis40,41. Similar 
to earlier descriptions of exosomal and circulating tRNAs, we identified primarily 18–35 nt fragments in our 
analysis, supporting the potential processing of tRNA to miRNA-like molecules8,9.
While numerous piRNAs and snoRNAs are found in the circulation, their significance in biological processes 
or diseases is unknown42,43. In our samples, the piRNAs were almost as abundant as the miRNAs. Canonical 
piRNAs are defined as small RNAs bound to PIWI proteins44. Recently, functional roles for piRNA beyond 
transposon silencing have emerged including genome rearrangement45, epigenetic regulation46 regulation of 
mRNA47 and lncRNAs48. piRNAs target the 3′UTR of several gene products that have to be degraded by acting 
Figure 7. Transfer of plasmodial RNAs to endothelial cells via EVs. (a) Bone marrow endothelial cells (BMECs) 
were incubated with 100 μg of PKH67 fluorescently labelled EVs for 0 or 6 h. BMECs were stained for actin 
(phalloidin, red) and nuclei (DAPI, blue). Scale bar, 10 μm. (b) Endothelial cells were incubated with 100 μg 
of EVs for 12 hours. After isolation of their RNA, the transfer of plasmodial RNA was measured by qPCR. The 
average and S.D. of 3 experiments is shown. (mean ± s.e.m.; n = 3 experiments), ***P < 0.0001 versus control 
(Student’s t-test). (c) Functional classification of the identified Plasmodium RNAs in EVs by gene ontology (GO) 
analysis conducted using Cytoscape with the Cluego plugin. This highlights the regulatory function, which 
plasmodial RNAs may exert in the recipient cells. (c) GO molecular function (d) GO cellular localization (e) 
GO biological function.
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similarly to miRNAs. Therefore, piRNAs may have potentially an important role in gene regulation and cellular 
communication.
Moreover, snoRNAs can give origin to shorter miRNA-like RNAs capable of regulating translation due to 
complementary interactions with mRNA49. The importance of snoRNAs in biological processes is illustrated by 
the absence of SNORD116 (SNO1354) in the Prader-Willi syndrome (PWS), a severe hereditary disease associ-
ated with obesity, mental retardation, and some other symptoms19,50.
PIR13807, which was the most abundant piRNA in our study, as well as PIR58593 were identified in the 
plasma of a large cohort of individuals42. SNO1408 (SNORD10) and SNO1257 (SNORD114) were also identified 
in plasma of healthy individuals42.
In addition, in our samples we found Y RNAs. Y RNAs are components of ribonucleoproteins (RNPs) 
complexed with Ro60 and La proteins. Although full length Y RNAs have a size of approximately 100 nt, 
high-throughput RNA sequencing has revealed that small Y RNA fragments, 22–36 nt, are also highly abundant 
in cells, tissues and body fluids including in EVs of humans, as well as in a range of tumors9,51,52.
We found that RNY4 is the most abundant in EVs. Interestingly Y RNA-derived fragment is the most abun-
dant fragment in plasma and serum in healthy patients52, as well as in EVs found in semen9.
Altogether, the function of the extracellular tRNAs, piRNAs, snoRNAs and Y-RNAs is currently unknown. 
Interestingly, only the processed forms of the RNAs were found in the EVs. Therefore, it can be speculated that 
the small RNAs are specifically targeted to the EVs. It is an intriguing possibility that small RNAs could mediate 
intercellular physiological signals to the hosts or between parasites.
While host small RNAs were the most abundant, we also found Plasmodium small RNAs such as tRNA, snoR-
NAs. In addition, we found Plasmodium mRNAs coding for proteins with gene regulatory properties such as the 
Alba proteins. The Alba proteins bind to RNA and fine tune the translation of RNAs linked to invasion53. We also 
identified Plasmodium RNAs with regulatory properties such as PFC0425w (Plant Homeodomain (PHD) finger 
protein) and PFF1185w (Smarca-related protein) which have chromatin-mediated gene regulation, as well as 
transcription factor with an AP2 domain (PF08_0074). It remains to be investigated whether the parasite mRNAs 
are translated in the recipient cells.
Parasite resistance to antimalarial drugs is an increasing problem in the fight against malaria54. Surprisingly, 
EVs carry host and Plasmodium RNAs involved in drug resistance. The vtRNAs are part of a large cellular rib-
onucleoparticles called vaults, which are implicated in chemotherapy resistance and have been implicated in 
the regulation of several cellular processes including transport mechanisms55, signal transmissions and immune 
responses56. vtRNAs are upregulated in several tumors where they mediate drug resistance, which can be 
conferred either by direct binding to chemotherapeutic compounds57,58 or by the regulation of expression of 
multidrug-associated proteins59. Whether vtRNA1-1 plays a role in acquiring drug resistance to malaria therapies 
is an intriguing possibility. It might act by binding to a drug to participate in the export of malaria therapeutics58.
Furthermore, we identified several parasite-derived mRNAs coding for proteins involved in drug resistance 
such as PFE1150w (multidrug resistance), PFL1410c (ABC transporter, multidrug resistance-associated protein 
2). As well as PFKELCH13, which is involved in artemisinin resistance60.
After alignment of the RNAseq reads against the plasmodial genome, we found that EVs contain plasmo-
dial RNAs. Most of the transcripts are derived from structural RNAs, including a few putative novel ncRNAs. 
We demonstrated the presence of PF11_0381a snoRNA U2 spliceosome in EVs and its EV-mediated transfer 
to endothelial cells. In addition, some plasmodial mRNAs were identified. Interestingly a large number of the 
Location Human Gene or comment
chr1:10,291,843-10,314,721 RNU6-1,2,7,8,9 intronic of KIF1B
chr1:91,344,238-91,430,371 HFM1 intronic
chr2:132,234,625-132,276,521 ANKRD30BL intronic (near MIR663B)
chr8:69,676,805-69,703,480 SLCO5A1 intronic
chr21:8,183,959-8,252,641 NR_038958 and 28 S RNA intronic (near MIR3648 and MIR663A)
chr21:8,393, 229-8,410,398 NR_038958 intronic and 28 S RNA exonic
chr21:8,429,258-8,463,598 28 S RNA 45 S RNA exonic
Location Plasmodium Gene or comment
many nearly all rRNA genes
Supercontig_1.3:841,093–845,256 T complexe protein PFC0900w
Supercontig_1.4:520,965-530,102 tRNA-Glu1
Supercontig_1.7:716,587–734,017 tRNA-Asp1
Supercontig_1.11:126,943-135,040 near PF11_0040-1 (3′utr?)
Supercontig_1.11:1,462,718-1,466,266 near PF11_0383-1 (promoter?)
Supercontig_1.12:582,683-593,330 near PFL0665c (promoter?)
Supercontig_1.13:1,568,006-1,594,376 tRNA-Pro1
Supercontig_1.13:1,632,229-1,633,112 snRNA-1 U6
Supercontig_1.13:2,793,179-2,807,332 several unknown function proteins (MAL13P1.430, 435, 440, 455, 460)
Supercontig_1.14:1,670,919-1,676,282 PF14_0390 unknown function protein
Table 2. Reads mapping to P. falciparum and Homo sapiens genomes.
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plasmodial mRNAs are coding for exported proteins61, such as PHIST B and PHIST C, PFA0110w, PFD1170c, 
MAL7P1.171, MAL7P1.172, PF08_0137. Why and how plasmodial RNAs are exported to EVs is not clear. 
However, the large percentage of small RNAs with potential gene regulatory function suggests they might be 
involved in cellular communication. The recent discovery of pathogen derived regulatory RNAs in several EVs 
suggests that regulatory RNAs may function in interspecies regulation involving microbial RNAs and host genes. 
It is possible that P. falciparum transfer its own RNAs via EVs to human cells to regulate gene expression to its own 
advantage. Some outstanding questions remain such as how P. falciparum targets specifically these RNAs to EVs 
or are the transferred RNAs transcribed in the target cells, either host cells or parasites.
While our and other results suggested that iRBCs secrete about 15 more EVs than uninfected RBCs, our cur-
rent results with the transfer of plasmodial RNA showed that our preparations may contain more than 80% EVs 
derived from iRBCs3,4.
Taken together our data identified for the first time the RNAs species contained in EVs. We found host as 
well as parasite derived RNAs. Most of the RNAs have gene regulatory functions and might therefore be involved 
in cellular communication. In addition, we found several RNAs involved in drug resistance and aspect that will 
require more investigations. Finally, we also found Plasmodium derived RNAs. Therefore, our study offers a wide 
range of new biomarkers as well as new potential pathways that can be targeted by drugs.
Materials and Methods
Cell culture of parasites. The P. falciparum strain 3D7 was used for this study. Parasites were kept in fresh 
type 0 + human red blood cells, suspended at 4% hematocrit in HEPES-buffered RPMI 1640 containing 10% 
(w/v) heat inactivated human serum, 0.5 ml Gentamycin, 2.01 g sodium bicarbonate and 0.05 g Hypoxanthine at 
pH 6.74. Prior to culture, the complete medium was depleted from extracellular vesicles and debris by ultracen-
trifugation at 100000 g for 1 hour. The parasite cultures were maintained in a controlled environment at 37 °C in 
a gassed chamber at 5% CO2 and 1% O2.
Synchronization of parasites. In order to obtain highly synchronized parasite cultures we performed a 
combination of Percoll and sorbitol. Parasites at 42–45 hours post-invasion were purified using a 70% Percoll. 
Fresh blood was added to the isolated schizonts. After 8 hours, 5% sorbitol was used to eliminate the remaining 
schizonts to yield highly synchronized rings.
Purification of EVs. EVs from iRBCs were isolated from cell culture supernatants as described3. In brief, 
cell culture supernatants of Plasmodium falciparum-infected RBCs were collected. Cells and cellular debris were 
removed from the supernatant by centrifugation at 600 g, 1600 g, 3600 g and finally 10000 g for 15 min. To further 
concentrate the EVs, the supernatant was filtered through a Vivacell 100 filter (100 kDa molecular weight cut off; 
Sartorius). Then, the concentrated supernatant was pelleted at 100000 g, the pellet resuspended in PBS and lay-
ered on top of a 60% sucrose cushion and spun at 100000 g for 16 hours. The interphase was collected and washed 
with PBS twice at 100000 g for 1 hour to yield EVs.
Isolation of RNA and gene expression studies in BMEC-1. Total RNA was isolated from EVs and 
BMEC-1 using miRNeasy kit (Qiagen, Hilden, Germany). The concentration and integrity of total RNA was 
measured using a NanoDrop-1000 spectrophotometer (Thermo Scientific, Wilmington, DE). Size distribution 
was determined by Agilent 2100 Bioanalyzer with the Agilent Small RNA Chip (Agilent Technologies, Santa 
Clara, CA).
For Plasmodial RNAs, reverse transcription reactions were performed with 1 μg total RNA using M-MLV 
Reverse Transcriptase kit (Promega) after DNase I treatment (Invitrogen).
Mature miR-451a and selected miRNAs were detected by quantitative RT-PCR (qRT-PCR) using TaqMan 
MicroRNA Reverse Transcription Kit (Applied Biosystems). Small nuclear RNA U6 (RNU6) (for miR-451a) and 
18 S rRNA and EF1 (for mRNAs) were used as reference genes for relative quantitation using the 2^− Ct method.
Metabolic labeling of RNA and imaging. Ring stage parasites at a parasitemia of about 5% (3D7), 
(15 hours post-invasion) were incubated at a final concentration of 0.5 mM 5-ethynyl uridine (EU) for 30 h. EVs 
were isolated from the conditioned medium as described above with exception of the sucrose gradient. The cells 
and EVs were subsequently fixed with 4% para-formaldehyde and permeabilized with 0.1% Triton-X-100. EU 
incorporated EV RNA was detected using Click chemistry according to the manufacturer’s protocol (Invitrogen, 
C10329) and nuclei were counterstained using Hoechst 33342 and analyzed with a MACSQuant VYB flow 
cytometer. Flow cytometry data acquisition was performed using FlowJo X (Tree Star, Ashland, OR).
Endothelial cell culture. A semi-immortalized human bone marrow derived endothelial cell line (BMEC-
1)62 was cultured in Endothelial Cell Growth Medium MV (Promocell) supplemented with 10% fetal bovine 
serum (Cedarlane, Burlington, Canada) and maintained at 37 °C under 5% CO2.
EV internalization assays with BMEC-1. Purified EVs were labelled with PKH67 red fluorescent labelling kit 
(Sigma-Aldrich) and incubated with BMECs for 12 h before washing cells three times to remove unbound EVs. 
For uptake inhibition experiments endothelial cells were co-incubated with different compounds, as described 
in Fig. 5. Cells were fixed, permeabilized and stained for F-actin with CF594 (Biotium) and with the nuclear dye 
DAPI (Sigma-Aldrich). Leica TCS SP5. Epifluorescence was performed on a Axiovert 200 M microscope (Carl 
Zeiss. Germany) equipped with a camera (Orca charge-coupled device; Hamamatsu Photonics, Japan) using a 
40 Plan-Neofluar (NA 1.3) oil immersion objective. Intensity analysis was performed with the Axiovision 4.6.3 
software. Background subtraction was performed for each field. Confocal microscopy was performed on a Zeiss 
LSM 510 Laser Scanning Microscope using a 63 Plan-Neofluar water-immersion objective.
www.nature.com/scientificreports/
13Scientific REPORTS |  (2018) 8:884  | DOI:10.1038/s41598-018-19149-9
Size exclusion chromatography. Experiments to determine possible presence of serum-derived 
Ago2-miRNA complexes were performed essentially as described7.
Briefly, sephacryl S-500 resin (GE Healthcare) was packed in a chromatography column (0.9 Å~ 30 cm, 
19.1 mL bed volume). Before injection, the column was equilibrated with 25 mL of PBS solution at 0.5 mL/min at 
room temperature. The column was injected with 0.5 mL of undiluted fresh serum or purified EVs and eluted at 
4 °C for approximately 1 h with PBS solution (pH 7.4) at a flow rate of 0.5 mL/min. A total of 25 fractions of 1 mL 
each were collected. Fractions were stored at 4 °C before use. Protein molecular weight standards included BSA 
(67 kDa; GE Healthcare) and tyrosine (0.181 kDa; Sigma-Aldrich).
Gene ontology analysis. ClueGO was used to find over-represented GO terms in the categories “biologi-
cal process”, “cellular component” and molecular function”. Benjamini-Hochberg correction was performed for 
multiple testing-controlled P values. The GO analysis was conducted using Cytoscape 3.2.1 software63 with the 
ClueGO64 plugin. The GO analysis was conducted using a two-sided hypergeometric test with Bonferroni correc-
tion. The GO term levels were from five to ten. The minimum number of genes to form a cluster was set at three, 
while the minimum percentage of genes covered by our data set against the database was set at 7%. The rest of the 
settings were left as defaults.
RNA-Seq. Each sequencing library was constructed from 2 ng of isolated and treated plasma RNA. All librar-
ies were uniquely bar-coded with index primer for multiplexing into sequencing lanes. The small RNA libraries 
were prepared and amplified using the NEBNext small RNA Library Prep Set (New England BioLabs, Ipswitch, 
MA, USA) following manufacturer instruction. The amplified libraries were resolved on a 10% Novex TBE gel 
(Life technologies) for size selection and the 140 to 160 nucleotide bands that correspond to adapter-ligated con-
structs derived from the 21 to 40 nucleotide RNA fragments were excise and recovered in DNA elution buffer. 
The average size distribution of each library was determined using Agilent Bioanalyzer with High Sensitivity 
Chip Kit (Agilent, Santa Clara, CA, USA) and quantified on ABI 7900HT Fast RT-PCR instrument using the 
KAPA Library Quantification kit according to the manufacture’s protocol (Kapa Biosystems, Woburn, MA, USA). 
Each library was adjusted to final concentration of 2 nM, pooled, and sequenced on an Illumina HiSeq. 2000 or 
MiSeq sequencer for single read 50 cycles at the Center for Cancer Computational Biology at Dana-Farber Cancer 
Institute.
Sequence Analysis. The BCL files were de-multiplexed using CASAVA v1.82, and the adaptor sequences 
within the read sequences were trimmed by FastX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit). The pro-
cessed sequences were filtered for small RNAs greater than 16 nucleotides in length. The sequences were then 
aligned, quantified and annotated using sRNABench 1.0 pipeline65. Briefly, the pipeline implemented hierarchi-
cal sequence mapping strategy that first mapped and remove spike-in library, contaminants, and rRNA before 
sequentially mapped to known mature miRNA, tRNA, snoRNA and piRNA onto the human genome sequence 
(hg19) using Bowtie266 with parameters that allow for 1 mismatch in seed alignment (-N 1), try two set of seeds 
(-R 2), and set the length of seed substrings to be 16 (-L 16). Mapped small RNA species was quantified to read 
counts and normalized to RPM as described in sRNABench. Detected species were mapped to mature miRNA 
only and not precursor miRNA. Reads derived from microRNA with multiple copies in the genome were summed 
together, and read counts from sample duplicates were aggregated by mean for where it is applicable. All statistical 
analysis was performed using R version 3.2.
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